Table 3.
Malignant lesions and participation in populations at elevated risk of advanced melanoma
| Men older than 50 | Others | p Value | >60 years old | <60 years old | p Value | |
|---|---|---|---|---|---|---|
| % (n/N) | % (n/N) | % (n/N) | % (n/N) | |||
| Proportion of included patients who attended the GP consultation | 66.0 (281/426) | 52.4 (1740/3319) | <0.001 | 72.4 (516/713) | 49.6 (1505/3032) | <0.001 |
| Proportion of patients referred to a dermatologist | 11.4 (32/281) | 12.4 (215/1740) | 0.72 | 10.7 (55/516) | 12.8 (192/1505) | 0.24 |
| Proportion of referred patients who actually consulted the dermatologist | 87.5 (27/32) | 66.5 (143/215) | 0.067 | 70.9 (39/55) | 68.2 (131/192) | 0.83 |
| Proportion of patients lost to follow-up | 10.0 (43/430) | 18.0 (522/2900) | <0.001 | 8.0 (62/775) | 19.0 (603/3174) | <0.001 |
| Proportion of overall patients who had a dermatological skin examination | 19.0 (81/426) | 16.1 (535/3319) | 0.15 | 17.7 (126/713) | 16.2 (490/3032) | 0.36 |
| Proportion of exeresis decision after dermatologist consultation | 21.0 (17/81) | 11.6 (62/535) | 0.029 | 15.9 (20/126) | 12.0 (59/490) | 0.32 |
| Proportion of malignant lesions among excised lesions | 66.7 (12/18) | 21.5 (14/65) | <0.001 | 66.7 (14/21) | 19.4 (12/62) | <0.001 |
| Crude incidence of melanoma | 469/105 | 120/105 | 0.14 | 420/105 | 99/105 | 0.09 |